ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
Having a regulatory compliance expert for a husband may have kick-started her cannabis career, but Nan-Maree Schoerie is ploughing her own path in the industry. In the first of a two-part interview with Cannabiz, she tells of the early days of Murray Meds and explains why greenhouse growing is no longer sustainable in Australia. Sometimes in…
Australian cannabis companies are standing out as making a cautious yet steady entry into the cannabis industry. One of these companies is ECS Botanics. “ECS Botanics started as a hemp company,” says Alex Keach, founder, and Managing Director of ECS Botanics. “We have a farm in Tasmania where we grow our cannabis outdoors.” The idea…
Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it to cure various illnesses. But increasing recreational use and perceived harm to society meant that it has been outlawed in many countries since the early 20th century. In the US for example, cannabis was restricted…
Dear shareholders, FY21 has been a defining year for the company as we start to leverage assets that we have established in proceeding years. These include our production base, industry leading team and culture, intellectual property and systems. As a result, the company is at a major inflection point. We are now in a position…
